Literature DB >> 7862640

Cell cycle-dependent regulation of p185neu: a relationship between disruption of this regulation and transformation.

N Kiyokawa1, D H Yan, M E Brown, M C Hung.   

Abstract

Structure and function of p185neu receptor tyrosine kinase were found to be regulated in a cell cycle-dependent manner. In M phase, p185neu is hyperphosphorylated at serine and/or threonine residues. The phosphotyrosine [Tyr(P)] content of p185neu is at its highest level in G0/G1 phase, decreases through S and G2 phases, and reaches its lowest level in M phase. Phospholipase C-gamma (PLC-gamma) and GTPase-activating protein (GAP), substrates of p185neu, also have a similar profile of Tyr(P) content during the cell cycle. These results, along with in vitro immune complex kinase assays, suggest that the tyrosine kinase activity of p185neu is least active in M phase. Interestingly, the mutation-activated neu oncogene (neu*)-encoded protein product, p185neu* escaped from cell cycle regulation. Taken together, we demonstrate in this report that the structure and function of p185neu are regulated in a cell cycle-dependent manner, yet p185neu* escapes from this regulation and remains active through the cell cycle. Disruption of this cell cycle regulation may define a mechanism for p185neu*-mediated cellular transformation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7862640      PMCID: PMC42643          DOI: 10.1073/pnas.92.4.1092

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Protein kinase cascades in meiotic and mitotic cell cycle control.

Authors:  S L Pelech; J S Sanghera; M Daya-Makin
Journal:  Biochem Cell Biol       Date:  1990-12       Impact factor: 3.626

2.  The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency.

Authors:  F Fazioli; U H Kim; S G Rhee; C J Molloy; O Segatto; P P Di Fiore
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

3.  Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells.

Authors:  D H Yu; M C Hung
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

4.  Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation.

Authors:  P L Chen; P Scully; J Y Shew; J Y Wang; W H Lee
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

5.  Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

Authors:  R Lupu; R Colomer; G Zugmaier; J Sarup; M Shepard; D Slamon; M E Lippman
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

6.  Cell cycle synchronization: reversible induction of G2 synchrony in cultured rodent and human diploid fibroblasts.

Authors:  R A Tobey; N Oishi; H A Crissman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Characterization of a neu/c-erbB-2 protein-specific activating factor.

Authors:  K Dobashi; J G Davis; Y Mikami; J K Freeman; J Hamuro; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.

Authors:  J R Bischoff; P N Friedman; D R Marshak; C Prives; D Beach
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

9.  Mammalian growth-associated H1 histone kinase: a homolog of cdc2+/CDC28 protein kinases controlling mitotic entry in yeast and frog cells.

Authors:  T A Langan; J Gautier; M Lohka; R Hollingsworth; S Moreno; P Nurse; J Maller; R A Sclafani
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

10.  Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase.

Authors:  B T Lin; S Gruenwald; A O Morla; W H Lee; J Y Wang
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

View more
  5 in total

1.  Controlling tumor-derived and vascular endothelial cell growth: role of the 4Ff2 cell surface antigen.

Authors:  M Papetti; I M Herman
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Induction of the Tat-binding protein 1 gene accompanies the disabling of oncogenic erbB receptor tyrosine kinases.

Authors:  B W Park; D M O'Rourke; Q Wang; J G Davis; A Post; X Qian; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

Review 3.  Immunologic approaches to inhibiting cell-surface-residing oncoproteins in human tumors.

Authors:  D M O'Rourke; M I Greene
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

4.  Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains.

Authors:  D M O'Rourke; X Qian; H T Zhang; J G Davis; E Nute; J Meinkoth; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

5.  Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells.

Authors:  D M O'Rourke; G D Kao; N Singh; B W Park; R J Muschel; C J Wu; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.